← brief for 2026-10-31 · Regeneration & devices

Subcutaneous Defibrillator for Primary Prevention in Chronic Kidney Disease Stage 3-5: The Single-Arm STEADIED Study.

Article B Peer reviewed Small trial

Key takeaways

This study tested a heart device in 39 people with kidney disease. The device is meant to stop sudden heart attacks. The study ended early, so it is small. It shows the device works in this group, but more people are needed to be sure.

Who did this work

Chung TW · Kim TH · Joung B · Park SJ · Choi EK · Bae MH · Park JS · Oh IY · Cho MS · Park JS · Jung MS · Park HS

Source

Article · PubMed, CKD progression and prevention · 2026 Oct 31
https://pubmed.ncbi.nlm.nih.gov/42963971/